Home Cart 0 Sign in  

[ CAS No. 500371-01-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 500371-01-7
Chemical Structure| 500371-01-7
Structure of 500371-01-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 500371-01-7 ]

Related Doc. of [ 500371-01-7 ]

Alternatived Products of [ 500371-01-7 ]

Product Details of [ 500371-01-7 ]

CAS No. :500371-01-7 MDL No. :MFCD29921839
Formula : C13H10O4 Boiling Point : -
Linear Structure Formula :- InChI Key :JBIHUDRUDVZFPT-UHFFFAOYSA-N
M.W : 230.22 Pubchem ID :46233840
Synonyms :

Calculated chemistry of [ 500371-01-7 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.08
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 61.34
TPSA : 56.51 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.93
Log Po/w (XLOGP3) : 1.47
Log Po/w (WLOGP) : 1.88
Log Po/w (MLOGP) : 0.14
Log Po/w (SILICOS-IT) : 3.02
Consensus Log Po/w : 1.69

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.45
Solubility : 0.813 mg/ml ; 0.00353 mol/l
Class : Soluble
Log S (Ali) : -2.26
Solubility : 1.26 mg/ml ; 0.00545 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.55
Solubility : 0.00643 mg/ml ; 0.0000279 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.8

Safety of [ 500371-01-7 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501 UN#:
Hazard Statements:H302-H312-H332 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 500371-01-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 500371-01-7 ]
  • Downstream synthetic route of [ 500371-01-7 ]

[ 500371-01-7 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 500371-01-7 ]
  • [ 119736-16-2 ]
YieldReaction ConditionsOperation in experiment
86% With sodium chlorite; aminosulfonic acid In water; acetone at 20℃; Cooling To an ice cooled aqueous (465 ml) solution of sodium chlorite (38.4 g, 424 mmol) and sulfamic acid (54.9 g, 566 mmol), acetone (465 ml) solution of compound B (46.5 g, 202 mmol) was added and the mixture was stirred for 40 minutes at room temperature. After removing acetone in vaccuo, precipitates were collected by filtration and washed with cold water. Compound C (42.8 g, 86percent) was obtained as colorless crystal. 1H-NMR(DMSO-d6) δ: 5.12(2H, s), 6.54(1 H, d, J=5.6Hz), 7.33-7.46(5H, m), 8.20(1 H1 d, J=5.6Hz).
86% With sodium chlorite; aminosulfonic acid In water; acetone at 20℃; for 0.666667 h; Cooling with ice To an ice cooled aqueous (465 ml) solution of sodium chlorite (38.4 g, 424 mmol) and sulfamic acid (54.9 g, 566 mmol), acetone (465 ml) solution of compound B (46.5 g, 202 mmol) was added and the mixture was stirred for 40 minutes at room temperature. After removing acetone in vaccuo, precipitates were collected by filtration and washed with cold water. Compound C (42.8 g, 86percent) was obtained as colorless crystal.
81% With sodium chlorite; aminosulfonic acid In water; acetone at 20℃; c) NaClO2, NH2SO3H, H2O/acelone, RT, 81percent;
80% With sodium chlorite; aminosulfonic acid In water; acetone for 3 h; 2) Sulfamic acid (1.50g, l5.dmmol) and NaClO2 (1.05g, 11.Gmmol) was added to the solution of compound 100 (2.54g, 11.0mmol) in acetone (20ml) and water (30ml). Then the mixture was stirred for 3h. The solvent was evaporated tinder reduced pressure to obtain compound 101 (2,18mg, 80percent) as a white solid. 1H-NMR (DMSO-ds)δ: 5J l(2H, s), 6.55(1H, d, J=5.4Hz), 7.32-7.46(5H, m), 8.21(3 H, d, J=5.7Hz).

Reference: [1] Medicinal Chemistry Research, 2013, vol. 22, # 5, p. 2351 - 2359
[2] Patent: WO2010/68262, 2010, A1, . Location in patent: Page/Page column 29
[3] Patent: JP5848595, 2016, B2, . Location in patent: Paragraph 0047
[4] Patent: WO2007/2109, 2007, A2, . Location in patent: Page/Page column 21
[5] Patent: WO2006/116764, 2006, A1, . Location in patent: Page/Page column 113
[6] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 12, p. 3257 - 3261
[7] Journal of the American Chemical Society, 2006, vol. 128, # 7, p. 2222 - 2223
[8] Patent: WO2010/67176, 2010, A1, . Location in patent: Page/Page column 13-14
[9] Journal of Medicinal Chemistry, 2017, vol. 60, # 8, p. 3498 - 3510
  • 2
  • [ 500371-01-7 ]
  • [ 1206102-07-9 ]
Reference: [1] Patent: JP5848595, 2016, B2,
[2] Patent: JP5848595, 2016, B2,
  • 3
  • [ 500371-01-7 ]
  • [ 1229006-21-6 ]
Reference: [1] Patent: JP5848595, 2016, B2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 500371-01-7 ]

Aryls

Chemical Structure| 216581-46-3

[ 216581-46-3 ]

3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 111782-87-7

[ 111782-87-7 ]

3-(Benzyloxy)-2-ethyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 18234-41-8

[ 18234-41-8 ]

5-(Benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 61049-69-2

[ 61049-69-2 ]

3-(Benzyloxy)-2-methyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 15771-06-9

[ 15771-06-9 ]

5-(Benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one

Similarity: 0.93

Aldehydes

Chemical Structure| 216581-46-3

[ 216581-46-3 ]

3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 18234-41-8

[ 18234-41-8 ]

5-(Benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Ethers

Chemical Structure| 216581-46-3

[ 216581-46-3 ]

3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 111782-87-7

[ 111782-87-7 ]

3-(Benzyloxy)-2-ethyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 18234-41-8

[ 18234-41-8 ]

5-(Benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 61049-69-2

[ 61049-69-2 ]

3-(Benzyloxy)-2-methyl-4H-pyran-4-one

Similarity: 1.00

Ketones

Chemical Structure| 216581-46-3

[ 216581-46-3 ]

3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 111782-87-7

[ 111782-87-7 ]

3-(Benzyloxy)-2-ethyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 18234-41-8

[ 18234-41-8 ]

5-(Benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 61049-69-2

[ 61049-69-2 ]

3-(Benzyloxy)-2-methyl-4H-pyran-4-one

Similarity: 1.00

Related Parent Nucleus of
[ 500371-01-7 ]

Pyrans

Chemical Structure| 216581-46-3

[ 216581-46-3 ]

3-(Benzyloxy)-6-methyl-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 111782-87-7

[ 111782-87-7 ]

3-(Benzyloxy)-2-ethyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 18234-41-8

[ 18234-41-8 ]

5-(Benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde

Similarity: 1.00

Chemical Structure| 61049-69-2

[ 61049-69-2 ]

3-(Benzyloxy)-2-methyl-4H-pyran-4-one

Similarity: 1.00

Chemical Structure| 15771-06-9

[ 15771-06-9 ]

5-(Benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one

Similarity: 0.93